{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:21:08Z","timestamp":1779888068468,"version":"3.53.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI138051"],"award-info":[{"award-number":["R21AI138051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI146380"],"award-info":[{"award-number":["R01AI146380"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"DOI":"10.13039\/100015515","name":"Carver College of Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015515","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Iowa Dance Marathon"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2021,1,14]]},"DOI":"10.1038\/s41388-020-01533-3","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T17:03:41Z","timestamp":1604336621000},"page":"345-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Deficiency of Wiskott\u2013Aldrich syndrome protein has opposing effect on the pro-oncogenic pathway activation in nonmalignant versus malignant lymphocytes"],"prefix":"10.1038","volume":"40","author":[{"given":"Seong-Su","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Kuang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4595-0267","authenticated-orcid":false,"given":"Yatin M.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"key":"1533_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","volume":"117","author":"HD Ochs","year":"2006","unstructured":"Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2006;117:725\u201338.","journal-title":"J Allergy Clin Immunol"},{"key":"1533_CR2","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1182\/blood-2008-12-115253","volume":"113","author":"M Bosticardo","year":"2009","unstructured":"Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia, Roncarolo M. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 2009;113:6288\u201395.","journal-title":"Blood"},{"key":"1533_CR3","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/j.jaci.2019.01.046","volume":"143","author":"M Cheminant","year":"2019","unstructured":"Cheminant M, Mahlaoui N, Desconclois C, Canioni D, Ysebaert L, Dupr\u00e9 L, et al. Lymphoproliferative disease in patients with Wiskott-Aldrich syndrome: analysis of the French Registry of Primary Immunodeficiencies. J Allergy Clin Immunol. 2019;143:2311\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"1533_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1468954","volume":"7","author":"M Keszei","year":"2018","unstructured":"Keszei M, Kritikou JS, Sandfort D, He M, Oliveira MMS, Wurzer H, et al. Wiskott-Aldrich syndrome gene mutations modulate cancer susceptibility in the p53\u00b1 murine model. Oncoimmunology 2018;7:e1468954.","journal-title":"Oncoimmunology"},{"key":"1533_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41591-018-0262-9","volume":"25","author":"M Menotti","year":"2019","unstructured":"Menotti M, Ambrogio C, Cheong TC, Pighi C, Mota I, Cassel SH, et al. Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma. Nat Med. 2019;25:130\u201340.","journal-title":"Nat Med"},{"key":"1533_CR6","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/onc.2016.366","volume":"36","author":"CA Murga-Zamalloa","year":"2017","unstructured":"Murga-Zamalloa CA, Mendoza-Reinoso V, Sahasrabuddhe AA, Rolland D, Hwang SR, McDonnell SR, et al. NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma. Oncogene 2017;36:2085\u201394.","journal-title":"Oncogene"},{"key":"1533_CR7","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1038\/onc.2016.518","volume":"36","author":"M Escoll","year":"2017","unstructured":"Escoll M, Gargini R, Cuadrado A, Anton IM, Wandosell F. Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP\/TAZ. Oncogene 2017;36:3515\u201327.","journal-title":"Oncogene"},{"key":"1533_CR8","first-page":"403","volume":"9","author":"J Hou","year":"2017","unstructured":"Hou J, Yang H, Huang X, Leng X, Zhou F, Xie C, et al. N-WASP promotes invasion and migration of cervical cancer cells through regulating p38 MAPKs signaling pathway. Am J Transl Res. 2017;9:403\u201315.","journal-title":"Am J Transl Res"},{"key":"1533_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127275","volume":"5","author":"A Hidalgo-Sastre","year":"2020","unstructured":"Hidalgo-Sastre A, Desztics J, Dantes Z, Schulte K, Ensarioglu HK, Bassey-Archibong B, et al. Loss of Wasl improves pancreatic cancer outcome. JCI Insight. 2020;5:e127275.","journal-title":"JCI Insight"},{"key":"1533_CR10","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1158\/0008-5472.CAN-18-1253","volume":"79","author":"H Li","year":"2019","unstructured":"Li H, Petersen S, Garcia Mariscal A, Brakebusch C. Negative Regulation of p53-Induced Senescence by N-WASP Is Crucial for DMBA\/TPA-Induced Skin Tumor Formation. Cancer Res. 2019;79:2167\u201381.","journal-title":"Cancer Res"},{"key":"1533_CR11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.cellsig.2011.04.001","volume":"23","author":"K Stengel","year":"2011","unstructured":"Stengel K, Zheng Y. Cdc42 in oncogenic transformation, invasion, and tumorigenesis. Cell Signal. 2011;23:1415\u201323.","journal-title":"Cell Signal"},{"key":"1533_CR12","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1242\/jcs.01115","volume":"117","author":"S Etienne-Manneville","year":"2004","unstructured":"Etienne-Manneville S. Cdc42-the centre of polarity. J Cell Sci. 2004;117:1291\u2013300.","journal-title":"J Cell Sci"},{"key":"1533_CR13","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-18-0619","volume":"78","author":"MDM Maldonado","year":"2018","unstructured":"Maldonado MDM, Dharmawardhane S. Targeting Rac and Cdc42 GTPases in Cancer. Cancer Res. 2018;78:3101\u201311.","journal-title":"Cancer Res"},{"key":"1533_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9:537\u201349.","journal-title":"Nat Rev Cancer"},{"key":"1533_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrd4204","volume":"13","author":"DA Fruman","year":"2014","unstructured":"Fruman DA, Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Disco. 2014;13:140\u201356.","journal-title":"Nat Rev Drug Disco"},{"key":"1533_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M. Nuclear factor-kappa B in cancer development and progression. Nature 2006;441:431\u20136.","journal-title":"Nature"},{"key":"1533_CR17","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/onc.2010.566","volume":"30","author":"MM Chaturvedi","year":"2011","unstructured":"Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB. NF-\u03baB addiction and its role in cancer: \u2018one size does not fit all\u2019. Oncogene 2011;30:1615\u201330.","journal-title":"Oncogene"},{"key":"1533_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ccr.2005.02.018","volume":"7","author":"DB Shankar","year":"2005","unstructured":"Shankar DB, Cheng JC, Kinjo K, Federman N, Moore TB, Gill A, et al. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell. 2005;7:351\u201362.","journal-title":"Cancer Cell"},{"key":"1533_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrc2681","volume":"10","author":"P Lopez-Bergami","year":"2010","unstructured":"Lopez-Bergami P, Lau E, Ronai Z. Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer. 2010;10:65\u201376.","journal-title":"Nat Rev Cancer"},{"key":"1533_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14335-8","volume":"11","author":"I Rey-Suarez","year":"2020","unstructured":"Rey-Suarez I, Wheatley BA, Koo P, Bhanja A, Shu Z, Mochrie S, et al. WASP family proteins regulate the mobility of the B cell receptor during signaling activation. Nat Commun. 2020;11:439.","journal-title":"Nat Commun"},{"key":"1533_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001704","volume":"11","author":"C Liu","year":"2013","unstructured":"Liu C, Bai X, Wu J, Sharma S, Upadhyaya A, Dahlberg CI, et al. N-wasp is essential for the negative regulation of B cell receptor signaling. PLoS Biol. 2013;11:e1001704.","journal-title":"PLoS Biol"},{"key":"1533_CR22","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/ng.3400","volume":"47","author":"E Stieglitz","year":"2015","unstructured":"Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, et al. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015;47:1326\u201333.","journal-title":"Nat Genet"},{"key":"1533_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4161\/cc.9.3.10554","volume":"9","author":"G Castellano","year":"2010","unstructured":"Castellano G, Torrisi E, Ligresti G, Nicoletti F, Malaponte G, Traval S, et al. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression. Cell Cycle. 2010;9:557\u201363.","journal-title":"Cell Cycle"},{"key":"1533_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3598","volume":"4","author":"C Ramkumar","year":"2013","unstructured":"Ramkumar C, Cui H, Kong Y, Jones SN, Gerstein RM, Zhang H. Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1. Nat Commun. 2013;4:2598.","journal-title":"Nat Commun"},{"key":"1533_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevOncog.2017021314","volume":"22","author":"W Wang","year":"2017","unstructured":"Wang W, Li D, Sui G. YY1 Is an Inducer of Cancer Metastasis. Crit Rev Oncog. 2017;22:1\u201311.","journal-title":"Crit Rev Oncog"},{"key":"1533_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/febs.13148","volume":"282","author":"K Beishline","year":"2015","unstructured":"Beishline K, Azizkhan-Clifford J. Sp1 and the \u2018hallmarks of cancer\u2019. FEBS J. 2015;282:224\u201358.","journal-title":"FEBS J."},{"key":"1533_CR27","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20140021","volume":"34","author":"L Tong","year":"2014","unstructured":"Tong L, Tergaonkar V. Rho protein GTPases and their interactions with NF\u03baB: crossroads of inflammation and matrix biology. Biosci Rep. 2014;34:e00115.","journal-title":"Biosci Rep."},{"key":"1533_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110627","volume":"9","author":"G Davuluri","year":"2014","unstructured":"Davuluri G, Augoff K, Schiemann WP, Plow EF, Sossey-Alaoui K. WAVE3-NF\u03baB interplay is essential for the survival and invasion of cancer cells. PLoS ONE. 2014;9:e110627.","journal-title":"PLoS ONE"},{"key":"1533_CR29","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ng.451","volume":"41","author":"CE Meacham","year":"2009","unstructured":"Meacham CE, Ho EE, Dubrovsky E, Gertler FB, Hemann MT. In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression. Nat Genet. 2009;41:1133\u20137.","journal-title":"Nat Genet"},{"key":"1533_CR30","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/sj.onc.1208177","volume":"24","author":"S Kurisu","year":"2005","unstructured":"Kurisu S, Suetsugu S, Yamazaki D, Yamaguchi H, Takenawa T. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 2005;24:1309\u201319.","journal-title":"Oncogene"},{"key":"1533_CR31","first-page":"a003236","volume":"2","author":"EY Lee","year":"2010","unstructured":"Lee EY, Muller WJ. Oncogenes and tumor suppressor genes. Cold Spring Harb Perspect Biol. 2010;2:a003236.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1533_CR32","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1159\/000495956","volume":"51","author":"LH Wang","year":"2018","unstructured":"Wang LH, Wu CF, Rajasekaran N, Shin YK. Loss of tumor suppressor gene function in human cancer: an overview. Cell Physiol Biochem. 2018;51:2647\u201393.","journal-title":"Cell Physiol Biochem"},{"key":"1533_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/path.5086","volume":"245","author":"HT Morris","year":"2018","unstructured":"Morris HT, Fort L, Spence HJ, Patel R, Vincent DF, Park JH, et al. Loss of N-WASP drives early progression in an Apc model of intestinal tumorigenesis. J Pathol. 2018;245:337\u201348.","journal-title":"J Pathol"},{"key":"1533_CR34","first-page":"3759","volume":"55","author":"E Farber","year":"1995","unstructured":"Farber E. Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res. 1995;55:3759\u201362.","journal-title":"Cancer Res"},{"key":"1533_CR35","doi-asserted-by":"publisher","first-page":"37ra44","DOI":"10.1126\/scitranslmed.3000813","volume":"2","author":"MD Taylor","year":"2010","unstructured":"Taylor MD, Sadhukhan S, Kottangada P, Ramgopal A, Sarkar K, D\u2019Silva S, et al. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome. Sci Transl Med. 2010;2:37ra44.","journal-title":"Sci Transl Med"},{"key":"1533_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4049\/jimmunol.1302923","volume":"193","author":"S Sadhukhan","year":"2014","unstructured":"Sadhukhan S, Sarkar K, Taylor M, Candotti F, Vyas YM. Nuclear role of WASp in gene transcription is uncoupled from its ARP2\/3-dependent cytoplasmic role in actin polymerization. J Immunol. 2014;193:150\u201360.","journal-title":"J Immunol"},{"key":"1533_CR37","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1182\/blood-2014-07-587642","volume":"124","author":"K Sarkar","year":"2014","unstructured":"Sarkar K, Sadhukhan S, Han SS, Vyas YM. Disruption of hSWI\/SNF complexes in T cells by WAS mutations distinguishes X-linked thrombocytopenia from Wiskott-Aldrich syndrome. Blood 2014;124:3409\u201319.","journal-title":"Blood"},{"key":"1533_CR38","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1182\/blood-2015-05-646182","volume":"126","author":"K Sarkar","year":"2015","unstructured":"Sarkar K, Sadhukhan S, Han SS, Vyas YM. SUMOylation-disrupting WAS mutation converts WASp from a transcriptional activator to a repressor of NF-\u03baB response genes in T cells. Blood 2015;126:1670\u201382.","journal-title":"Blood"},{"key":"1533_CR39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nm1087","volume":"10","author":"B Vogelstein","year":"2004","unstructured":"Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789\u201399.","journal-title":"Nat Med"},{"key":"1533_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaci.2017.11.023","volume":"142","author":"K Sarkar","year":"2018","unstructured":"Sarkar K, Han SS, Wen KK, Ochs HD, Dupr\u00e9 L, Seidman MM, et al. R-loops cause genomic instability in T helper lymphocytes from patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2018;142:219\u201334.","journal-title":"J Allergy Clin Immunol"},{"key":"1533_CR41","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jaci.2019.09.026","volume":"145","author":"KK Wen","year":"2020","unstructured":"Wen KK, Han SS, Vyas YM. Wiskott-Aldrich syndrome protein senses irradiation-induced DNA damage to coordinate the cell-protective Golgi dispersal response in human T and B lymphocytes. J Allergy Clin Immunol. 2020;145:324\u201334.","journal-title":"J Allergy Clin Immunol"},{"key":"1533_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41586-018-0237-5","volume":"559","author":"BR Schrank","year":"2018","unstructured":"Schrank BR, Aparicio T, Li Y, Chang W, Chait BT, Gundersen GG, et al. Nuclear ARP2\/3 drives DNA break clustering for homology-directed repair. Nature 2018;559:61\u201366.","journal-title":"Nature"},{"key":"1533_CR43","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3390\/ijms18081808","volume":"18","author":"S Kawanishi","year":"2017","unstructured":"Kawanishi S, Ohnishi S, Ma N, Hiraku Y, Murata M. Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis. Int J Mol Sci. 2017;18:1808.","journal-title":"Int J Mol Sci"},{"key":"1533_CR44","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646\u201374.","journal-title":"Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01533-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T11:18:40Z","timestamp":1650539920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01533-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1,14]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1038\/s41388-020-01533-3","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,2]]},"assertion":[{"value":"19 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}